Journals / Turkish Journal of Pediatrics / 2015 / Cilt: 57 - Sayı: 5

Empiric treatment of children with gastroesophageal reflux- like symptoms: Effect of proton pump inhibitors

Pages
482–486
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However it is important to investigate non-responders to empiric therapy, as it seems there might be high probability of pathological findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gündüz M, Yamaç P, Baysoy G.
📊
Key Findings & Data:Turk J Pediatr 2015; 57: 482-486.Gastroesophageal reflux disease is an important cause of morbidity in childhood.
💡
Conclusion & Impact:However it is important to investigate non-responders to empiric therapy, as it seems there might be high probability of pathological findings.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Gündüz M, Yamaç P, Baysoy G. Empiric treatment of children with gastroesophageal reflux-like symptoms: Effect of proton pump inhibitors. Turk J Pediatr 2015; 57: 482-486.Gastroesophageal reflux disease is an important cause of morbidity in childhood. Although various diagnostic methods are available, short course of empiric treatment with a proton pump inhibitor is widely used in adults as a diagnostic test. Data about empiric treatment is scarce in children. The aim of this study is to evaluate the effectiveness of empiric treatment of reflux-like symptoms in children.Pediatric gastroenterology outpatient files were searched and patients with a diagnosis of gastroesophageal reflux were found. Patient complaints, history and the treatments provided were recorded. Treatment naive patients older than 2 years of age with symptoms suggestive of gastroesophageal reflux were selected and included if they were given empiric treatment with a proton pump inhibitor. Empiric treatment was found to be effective in 78% of patients. Treatment response tended to be better in children older than 5 years of age. Of the 22 non-responders 9 underwent endoscopy and pathological findings were discovered in 7 of them. Treatment of children with gastroesophageal reflux symptoms with a proton pump inhibitor might significantly decrease the need for extensive evaluations. However it is important to investigate non-responders to empiric therapy, as it seems there might be high probability of pathological findings.

🔖

Cite This Article

GÜNDÜZ, M., BAYSOY, G., YAMAÇ, P. (2022). Empiric treatment of children with gastroesophageal reflux- like symptoms: Effect of proton pump inhibitors. Turkish Journal of Pediatrics, Cilt: 57 - Sayı: 5, 482–486. https://ajindex.com/articles/613245

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Po d d a r U. D i a g n o s i s a n d m a n a g e m e n t o f gastroesophageal reflux disease (GERD): an Indian perspective. Indian Pediatr 2013; 50: 119-126
  2. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 2000; 154: 150-154
  3. Bor S, Mandiracioglu A, Kitapcioglu G, Caymaz-Bor C, Gilbert RJ. Gastroesophageal reflux disease in a lowincome region in Turkey. Am J Gastroenterol 2005; 100: 759-765
  4. Kwon HJ YD, Ryoo E, Cho KH, Son DW, Tcha H. Prevalence and risk factors associated with esophagitis in children with abdominal pain. Korean J Pediatr Gastroenterol Nutr 2008; 11: 103-109
  5. Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Inten Med 1999; 159: 2161-2168
  6. Fass R, Ofman JJ, Sampliner RE, Camargo L, Wendel C, Fennerty MB. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000; 14: 389-396
  7. Dean BB, Gano AD, Jr., Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-664
  8. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2006; 24: 371-376
  9. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49: 498-547
  10. Gold BD, Gunasekaran T, Tolia V, et al. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007; 45: 520-529
  11. Tolia V, Bishop PR, Tsou VM, et al. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2006; 42: 384-391
  12. Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L. Efficacy of lansoprazole in the tre